The detection of clinically relevant RECQL4 mutations demonstrated the dual roles of RECQL4 helicases: first in maintaining the genome integrity, secondly in DNA repair which determines responses to therapeutic drugs in the case of cancer. Here, RECQL4 is linked to cancer.